atovaquone
Selected indexed studies
- Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria. (Cochrane Database Syst Rev, 2021) [PMID:33459345]
- Atovaquone: a review. (Ann Pharmacother, 1993) [PMID:8305784]
- Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature. (Med Mycol, 2023) [PMID:37656874]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria. (2021) pubmed
- Atovaquone-proguanil for prophylaxis and treatment of malaria. (2003) pubmed
- Atovaquone and proguanil hydrochloride for treatment of malaria. (1999) pubmed
- Atovaquone and proguanil hydrochloride: a review of nonclinical studies. (1999) pubmed
- Atovaquone and proguanil hydrochloride for prophylaxis of malaria. (1999) pubmed
- Atovaquone: a review. (1993) pubmed
- Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature. (2023) pubmed
- Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito. (2023) pubmed
- Antiparasitic agent atovaquone. (2002) pubmed
- Atovaquone: a new antipneumocystis agent. (1993) pubmed